This study found significant immune heterogeneity between sDPLA lesions with different degrees of invasiveness and identified CD4+ Tex CXCL13 cells as key drivers of tumor immune progression. Our findings provide new insights into early immune evolution and may inform precision immunotherapy strategies.
Chen et al. (Thu,) studied this question.